Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.

समान संसाधन

• Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
  द्वारा: Munderi, P, और अन्य
  प्रकाशित: (2010)
• Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
  द्वारा: Walker, A, और अन्य
  प्रकाशित: (2010)
• Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study.
  द्वारा: Gomo, Z, और अन्य
  प्रकाशित: (2014)
• DART and laboratory monitoring of HIV treatment Reply
  द्वारा: Walker, A, और अन्य
  प्रकाशित: (2010)
• Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
  द्वारा: Mugyenyi, P, और अन्य
  प्रकाशित: (2010)